Gene Query: SEMA4B

Dataset Description Geneva Score
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 119.19
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 87.94
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 69.61
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 67.53
TCF7L1 knockdown in pancreatic cancer 66.27
Transcriptomic analysis of LSD1 65.98
Transcriptome analysis of kidney organoids 65.71
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 62.26
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 54.92
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 52.66
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 52.56
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 51.72
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 47.66
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 47.16
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 47.16
Transcriptomic analysis of ERR alpha orphan nuclear receptor 44.74
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 44.04
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 43.36
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 40.47
RNA sequencing of GlyH-101-treated MCF-7 cell line 40.02
HNF1 regulates critical functions of the human epididymis epithelium. 39.68
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 39.68
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 39.01
Primary Human B-cell Temporal Response to CD40L Stimulation 38.63
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 37.38
Landscape of H3K4me3 in human CD19 cells 36.98
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 36.07
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 35.84
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 35.67
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 35.23
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 34.12
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  33.67
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 33.57
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 33.57
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 32.99
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 32.2
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 32.12
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 31.99
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 31.96
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 31.95
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 31.92
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 30.95
Statins modulate endothelial transcriptional profile by inhibiting EZH2 30.7
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 30.52
RNA-seq of shEZH2 cells 30.42
Gene Expression Profiling of SPOP Knocked Down Cell 29.54
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 29.41
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 28.24
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 28.05
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 28.05
TGF-β regulation of miRNA expression in pancreatic cancer 27.97
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 27.63
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 27.49
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 27.26
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 26.96
MCF10A H-Ras RNA-Seq 26.07
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 26.04
Transcriptome profiling of Normal and Cancerous Prostate Cells 25.75
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 25.69
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 25.31
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 25.13
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 24.95
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 23.93
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 23.5
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 23.3
A prostate cancer chromatin interaction map 23.28
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 23.24
Functional role of CPPED1 in trophoblasts. 22.85
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 22.5
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 22.46
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 22.46
CD73 knockdown effect in pancreatic cancer cell lines 22.26
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 22.21
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 22.01
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 21.53
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 21.44
The role of FAM46C in myeloma cells [sequencing] 21.32
The role of FAM46C in myeloma cells 21.32
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 21.04
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 20.97
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 20.68
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 20.63
Transcriptomic and gene ontology profiling of the human corneal cell types 20.5
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 20.39
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 20.23
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 20.14
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 19.59
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 19.47
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 19.47
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 19.06
Functional role of SLIT2 and ROBO1 in trophoblasts 18.99
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 18.37
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 18.37
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 18.26
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 18.26
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 18.09
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 18.09
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 18.07
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 18.07
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 17.88
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 17.85
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 17.79
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 17.72
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 17.7
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 17.59
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 17.57
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 17.53
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 17.47
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 17.4
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 17.11
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 17.09
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 16.95
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 16.9
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 16.85
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 16.73
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 16.56
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 16.42
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 16.42
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 16.4
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 16.33
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 16.03
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 15.8
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 15.79
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 15.69
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 15.45
Transcriptome analysis of U87 cells upon LINC00152 knockdown 15.43
NHLRC1 re-expression in cancer cells 15.13
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 15.01
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 14.99
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 14.81
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 14.76
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 14.3
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 14.22
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 14.15
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 14.05
circRNA profile in hypopharyngeal cancer 14.04
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 14.04
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 13.95
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 13.9
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 13.88
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 13.73
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 13.71
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 13.48
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 13.44
U2AF1 mutations alter splice site recognition in hematological malignancies 13.42
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 13.27
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 13.27
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 13.26
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 13.26
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 13.17
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 13.17
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 13.15
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 12.95
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 12.88
Generation of KRAS signatures using immortalized isogenic lung cells. 12.84
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 12.8
Nutritional control of protein translation 12.74
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 12.68
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 12.6
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 12.6
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 12.59
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 12.58
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 12.58
Tpl-2 small molecule project 12.44
Tpl-2 and MEK small molecule inhibitors 12.44
BACH2 in human plasma cell fate decision 12.44
Effect of ILF3 on translation during homeostasis and the antiviral response 12.42
Intron retention induced by microsatellite expansions as a disease biomarker. 12.4
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 12.4
Selective expression of long non-coding RNAs in a breast cancer cell progression model 12.39
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 12.36
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 12.33
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 12.28
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 12.25
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 12.05
Accurate annotation of human protein-coding small open reading frames 12.03
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 11.96
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 11.95
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 11.92
MYCi975 regulates MYC target genes 11.87
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 11.77
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 11.77
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 11.77
Gene Expression Profiling of WT and KDM3A Knocked out Cell 11.76
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 11.76
Transcriptome analyses of human pancreatic islets and pseudoislets 11.74
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 11.57
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 11.55
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 11.54
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 11.54
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 11.52
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 11.51
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 11.51
RNA sequencing of mechanically strained NHEKs and control NHEKs 11.5
AUF-1 affected genes in human skin cells 11.37
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 11.31
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 11.31
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 11.3
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 11.3
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 11.22
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 11.2
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 11.18
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 11.18
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 11.13
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 11.11
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 11.1
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 11.09
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 11.09
Characterization of parental and rociletinib-resistant derived H1975 cell lines 11.06
RNA-sequencing in irradiated and normal A549 cells. 11.06
MYCi361 regulates MYC target genes 11.04
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 10.99
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 10.9
Effect of Influenza virus infection on lncRNA expression in A549 cells 10.85
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 10.83
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 10.82
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 10.8
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 10.78
Differential gene expression of human melanoma cells [RNA-seq] 10.78
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 10.68
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 10.68
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 10.67
Bone marrow derived human B cells [normal proB] 10.66
Transcriptional profiles of normal human mature B cells 10.64
FOXP1 orchestration of ASD-relevant signaling pathways. 10.64
EWSR1 influences alternative splicing through direct and indirect mechanisms 10.6
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 10.57
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 10.56
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 10.43
Genome wide expression change by RNF168 knocking down in NEC cells 10.38
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 10.34
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 10.32
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 10.32
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 10.31
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 10.31
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 10.23
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 10.18
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 10.12
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 10.1
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 10.04
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 10.02
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 10.0
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 9.98
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 9.97
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 9.92
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 9.9
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 9.84
Chromatin-informed inference of transcriptional programs in gynecologic cancers 9.84
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 9.74
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 9.7
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 9.7
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 9.7
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 9.69
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 9.62
TFAP2C signalling in human fibroblasts 9.61
DIGIT regulates endoderm differentiation of human embryonic stem cells 9.58
JunB control of keratinocyte-mediated inflammation [RNA-seq] 9.57
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 9.57
Silencing p300 in MCF7 cells to study expression and alternative splicing 9.56
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 9.53
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 9.45
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 9.45
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 9.45
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 9.45
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 9.24
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 9.24
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 9.19
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 9.17
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 9.13
Region-specific Innate Antiviral Responses of the Human Epididymis 9.12
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 9.12
METTL3 promotes translation in human cancer cells 9.03
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 9.02
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 8.99
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 8.95
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 8.9
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 8.9
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 8.87
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 8.85
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 8.81
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 8.74
The effect of Abl kinases on non-small cell carcinoma global transcriptome 8.69
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 8.68
The Genomic Landscape of Atypical Fibroxanthoma 8.68
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 8.67
Regulation of hypoxia-inducible factor activity by ZMYND8 8.62
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 8.61
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 8.57
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 8.57
Genome-wide chromatin analysis of Ewing sarcoma 8.52
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 8.52
A map of gene expression in neutrophil-like cell lines 8.49
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 8.42
Transcriptome analysis of H9 hESC derived cerebral organoids 8.39
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 8.35
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 8.34
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 8.33
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 8.33
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 8.3
SRSF2 mutations impair hematopoiesis and alter exon recognition 8.28
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 8.26
In situ CAPTURE of chromatin interactions by biotinylated dCas9 8.25
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 8.25
RNA-seq of tumor cells following angiopellosis extravasation 8.13
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 8.11
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 8.06
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 8.06
RNA seq_PDX2_SHP099 7.96
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 7.86
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 7.83
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 7.83
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 7.76
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 7.72
Changes in human endometrial gland transcriptome over the window of implantation 7.57
CircRNAome diversity in human mature B-cells, T-cells and monocytes 7.55
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 7.54
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 7.5
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 7.48
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 7.45
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 7.44
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 7.43
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 7.43
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 7.4
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 7.39
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 7.39
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 7.36
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 7.36
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 7.28
6mer seed toxicity in tumour suppressive microRNAs 7.25
RNA-Seq in neutrophils from Antiphospholipid Syndrome 7.21
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 7.15
Genome-wide analysis of Dengue virus 2 infected cells 7.15
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 7.13
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 7.05
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 7.03
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 7.03
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 7.02
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 7.02
Sensing self and nonself circular RNAs 6.89
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 6.88
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 6.83
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 6.83
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 6.77
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 6.77
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 6.77
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 6.68
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 6.61
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 6.44
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 6.31
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 6.29
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 6.28
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 6.28
H1609088 Human RNA-Sequencing 6.16
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 6.09
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 6.03
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 6.0
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 5.96
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.9
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 5.9
BASP1 modifies the Tamoxifen response 5.89
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 5.82
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 5.82
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 5.8
Effect of nuclear IL-33 on gene expression 5.78
Gene expression profile difference among renal location in a stone former 5.77
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 5.71
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 5.67
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 5.67
Be1 and Be2 B cells are transcriptionally distinct 5.65
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 5.57
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 5.55
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 5.54
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 5.37
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 5.37
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 5.27
RNA-seq differential expression studies: more sequence, or more replication? 5.21
RNA-seq of SCLC PDX models treated with EP 5.04
MRTF activates TEAD-YAP target gene expression 4.95
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 4.88
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 4.75
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 4.69
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 4.57
CD74 role in transcription regulation 4.53
CD74 role in transcription regulation [RNA-seq] 4.53
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 4.45
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 4.43
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 4.42
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 4.29
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 4.22
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 4.22
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 4.22
IRF1 regulates IFN dependent and independent gene expression 4.19
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 4.18
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 4.18
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 4.07
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 4.0
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 3.93
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 3.9
Loss of endometrial plasticity in recurrent pregnancy loss 3.9
Dysregulated immune system networks in war veterans with PTSD 3.84
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 3.82
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 3.81
Transcriptome of U251 cells overexpression complement component 7 3.76
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 3.74
Gene expression of thyroid cancer cell lines 3.73
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 3.69
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 3.63
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 3.55
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 3.52
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 3.41
FOXP2's impact on the primate transcriptome 3.29
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 3.27
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 3.26
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 3.23
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 3.17
Gene expression analysis of human liver progenitor-like cells in culture 3.15
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 3.08
Functional astrocytes differentiated from hiPSCs 3.04
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 3.02
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 3.01
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 3.01
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 2.93
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 2.93
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 2.85
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 2.82
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 2.77
Genome-wide identification of cancer-specific alternative splicing in circRNA 2.69
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 2.64
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 2.63
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 2.51
Effect of BB608 on Gene Expression in HNSCC Cell Line 2.42
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 2.42
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 2.35
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 2.34
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.31
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 2.31
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 2.3
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 2.28
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 2.25
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 2.21
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 2.2
Human ovarian granulosa cell transcriptome 2.1
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 2.08
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 2.06
Alagille_Nodder 2.0
RNA Seq of Alagille liver biopsies 2.0
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 1.93
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 1.92
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 1.92
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 1.88
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 1.78
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 1.77
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 1.77
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 1.68
RNA-seq of cancer cell lines treated with T-025 1.67
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 1.63
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 1.62
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 1.59
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 1.59
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.57
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 1.55
Direct Isolation and Characterization of Human Nephron Progenitors. 1.49
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 1.46
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 1.43
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 1.43
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 1.43
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 1.4
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 1.31
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 1.26
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 1.24
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 1.23
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.23
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 1.13
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 1.12
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 1.09
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 1.06
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 1.06
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 1.05
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 0.99
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 0.72
Aneuploidy-induced cellular stresses limit autophagic degradation. 0.71
Finding missing proteins from epigenetically manipulated human cells 0.65
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.55
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.52
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.52
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.5
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.38
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.37
Molecular analysis of renal cell carcinoma with unclassfied histology 0.37
Transcriptomic analysis of human macrophages in 3D 0.3
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.26
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.24
Gene expression analysis of human adenomas. 0.19
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 0.17
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.07
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 0.07
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.07
Metastasis in triple-negative breast cancer 0.07
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.05
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation